SGLT2 inhibitors and outcomes in pancreatic cancer: A large-scale propensity-matched cohort study.
Chidiebube J. Ugwu(Jefferson Hospital), Alankrita Taneja(Sidney Kimmel Cancer Center), Muluken Megiso(Jefferson Hospital), Chimezirim Ezeano(Aurora Health Care), Elvis Obomanu(Jefferson Einstein Philadelphia Hospital), Nneoma Ubah(Montefiore Medical Center), Colton Jones(Thomas Jefferson University), Nnamdi Joseph Omenuko(East Tennessee State University), Karecia Byfield(Jefferson Einstein Philadelphia Hospital), Tarfa Verinumbe(Albert Einstein College of Medicine)
Cited by 0
Related Papers
Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020
|AIDS|2021|16
Characterizing the Relationship between HIV Peer Support Groups and Internalized Stigma Among People Living with HIV in Nigeria
|AIDS and Behavior|2023|15
Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
|Drug and Alcohol Dependence Reports|2024|4
GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.
|Journal of Clinical Oncology|2026|3